The FDA issues an alert on March 18, 2008, about serious skin reactions occurring in patients receiving anti-TNF meds such as Remicade. The description of the peeling skin sounds like what was described in the alert:
"The serious skin reactions presented mostly with rash and skin lesions on the trunk, limbs, shoulder, back, hands, and face. In some SJS cases, oral mucositis or ulceration, genital ulceration, and/or fever were also reported. An allergic-type reaction occurred in 1 patient who first had hives and swollen lips, eyes, and face, followed by EM lesions on her back and hypoxia.
In a few cases of TEN, the skin reactions consisted of desquamation and progressive, generalized pruritus and skin peeling; a severe, scaly, pigmented, necrotizing rash over the body; and erythema with blepharoconjunctivitis, angioedema, and tightness in the throat."
Moderator Crohn's Disease Forum
CD, Ankylosing Spondylitis, lupus, small fiber peripheral neuropathy, avascular necrosis, peripheral artery disease, degenerative disc disease, and a host of other medical problems.